Rheumatoid Arthritis
Rheumatoid arthritis (RA) is an autoimmune disorder that causes chronic inflammation of the joints, leading to pain, swelling, and potential joint damage. It can also affect other systems in the body.
Rheumatoid Arthritis: CLN-978 Treatment
We are testing a new treatment called CLN-978 for patients with rheumatoid arthritis who haven't found relief from existing medications. The goal is to see if it can help manage their symptoms better.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitaetsklinikum Erlangen AöR
Medizinische Klinik 3 – Rheumatologie und Immunologie
Erlangen, Germany
Universitaetsklinikum Heidelberg AöR
Klinik für Hämatologie, Onkologie und Rheumatologie Innere Medizin V
Heidelberg, Germany
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
UOC Rheumatology
La Massimina-Casal Lumbroso, Italy
Sponsor: Cullinan Therapeutics Inc.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.